These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 7732605

  • 1. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB, Tanzer FN, Atalay A.
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA, Abdella MM.
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Valproate-associated hyperammonemia and DL-carnitine supplement.
    Komatsu M, Kodama S, Yokoyama S, Konishi H, Tanaka K, Momota K, Wada H, Matsuo T.
    Kobe J Med Sci; 1987 Jun; 33(3):81-7. PubMed ID: 2959815
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G, Epifanio G, Auricchio G, Federico RR, Resicato G, Pascotto A.
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [Abstract] [Full Text] [Related]

  • 10. Valproate therapy does not deplete carnitine levels in otherwise healthy children.
    Hirose S, Mitsudome A, Yasumoto S, Ogawa A, Muta Y, Tomoda Y.
    Pediatrics; 1998 May; 101(5):E9. PubMed ID: 9565442
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP.
    Int J Vitam Nutr Res; 1995 May; 65(3):211-4. PubMed ID: 8830002
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of phenytoin and valproic acid therapy on serum lipid levels and liver function tests.
    Dewan P, Aggarwal A, Faridi MM.
    Indian Pediatr; 2008 Oct; 45(10):855-8. PubMed ID: 18948659
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?
    Chicharro AV, de Marinis AJ, Kanner AM.
    Epilepsy Behav; 2007 Nov; 11(3):361-6. PubMed ID: 17845866
    [Abstract] [Full Text] [Related]

  • 17. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
    Yokoyama S, Yasui-Furukori N, Nakagami T, Miyazaki K, Ishioka M, Tarakita N, Kubo K, Sugawara N, Shimoda K.
    Ther Drug Monit; 2020 Oct; 42(5):766-770. PubMed ID: 32482992
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of ghrelin in weight gain and growth in epileptic children using valproate.
    Gungor S, Yücel G, Akinci A, Tabel Y, Ozerol IH, Yologlu S.
    J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
    [Abstract] [Full Text] [Related]

  • 20. Effects of levetiracetam and valproic acid treatment on liver function tests, plasma free carnitine and lipid peroxidation in childhood epilepsies.
    Haznedar P, Doğan Ö, Albayrak P, Öz Tunçer G, Teber S, Deda G, Eminoglu FT.
    Epilepsy Res; 2019 Jul; 153():7-13. PubMed ID: 30925397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.